Middle East respiratory syndrome: what clinicians need to know

Mayo Clin Proc. 2014 Aug;89(8):1153-8. doi: 10.1016/j.mayocp.2014.06.008. Epub 2014 Jul 14.

Abstract

A severe viral illness caused by a newly discovered coronavirus was first reported in the Middle East in 2012. The virus has since been named the Middle East respiratory syndrome coronavirus (MERS-CoV). MERS-CoV cases have been reported in several countries around the world in travelers from the Middle East. The illness has a high mortality rate. Limited human-to-human transmission has occurred including transmission to health care workers. The source of the virus remains unclear, but camels are a possible source. Two unrelated imported cases of MERS-CoV have been reported in the United States. Neither a vaccine nor effective therapy against the virus is available. International cooperation and information sharing will be key to understanding and ending the MERS-CoV outbreak.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Adult
  • Coronavirus / isolation & purification
  • Coronavirus / pathogenicity
  • Coronavirus Infections / epidemiology*
  • Coronavirus Infections / prevention & control
  • Coronavirus Infections / transmission
  • Coronavirus Infections / virology
  • Disease Outbreaks / prevention & control*
  • Disease Outbreaks / statistics & numerical data
  • Global Health
  • Health Personnel
  • Humans
  • Infection Control / methods*
  • Infection Control / standards
  • Infectious Disease Transmission, Patient-to-Professional
  • Male
  • Middle East / epidemiology
  • Saudi Arabia / epidemiology
  • Severe Acute Respiratory Syndrome / epidemiology*
  • Severe Acute Respiratory Syndrome / prevention & control
  • Severe Acute Respiratory Syndrome / transmission
  • Severe Acute Respiratory Syndrome / virology
  • Travel
  • United States